pPV-Dual_promoter-EF1α-2xNLS-Cascade+Cas3-P (RD) Citations (2)
Originally described in: CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.Morisaka H, Yoshimi K, Okuzaki Y, Gee P, Kunihiro Y, Sonpho E, Xu H, Sasakawa N, Naito Y, Nakada S, Yamamoto T, Sano S, Hotta A, Takeda J, Mashimo T Nat Commun. 2019 Dec 6;10(1):5302. doi: 10.1038/s41467-019-13226-x. PubMed Journal
Articles Citing pPV-Dual_promoter-EF1α-2xNLS-Cascade+Cas3-P (RD)
| Articles |
|---|
Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs.
Kita Y, Okuzaki Y, Naoe Y, Lee J, Bang U, Okawa N, Ichiki A, Jonouchi T, Sakurai H, Kojima Y, Hotta A.
Stem Cell Reports. 2023 Sep 12;18(9):1753-1765. doi: 10.1016/j.stemcr.2023.07.007. Epub 2023 Aug 24.
PubMed
Associated Plasmids |
| Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes. Yoshimi K, Kuno A, Yamauchi Y, Hattori K, Taniguchi H, Mikamo K, Iida R, Ishida S, Goto M, Takeshita K, Ito R, Takahashi R, Takahashi S, Mashimo T. Cell Rep Methods. 2024 Aug 19;4(8):100833. doi: 10.1016/j.crmeth.2024.100833. Epub 2024 Aug 8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.